New research brings awareness to potential heart problems linked to non-stimulant prescription drugs for the condition. In a ...

A large new analysis of 102 clinical trials finds that ADHD medications have overall small effects on blood pressure and heart rate in both children and adults.

A new study has found that ADHD medications could have cardiovascular side effects, such as increased blood pressure and ...

Systolic blood pressure (BP): a high of +1.81 mmHg with methylphenidate in children (moderate level of evidence) and +2.3 ...

Elite Pharmaceuticals announced the launch of its generic version of Vyvanse® (Lisdexamfetamine Disylate) in various strengths, targeting the ADHD treatment market. The product, which is marketed ...

Shionogi is an established player in the Japanese ADHD market with Vyvanse (lisdexamfetamine dimesylate), one of the only stimulant drugs approved for use by the MHLW- although, since 2020 ...

Vyvanse (lisdexamfetamine) is among the top-selling drugs in the U.S., with 2023 sales of $2.5–3B+ annually. In 2024, the U.S. faced a scarcity of over 300+ different drugs, including ADHD ...

However, it is known that other manufacturers have struggled, with Takeda also citing ‘manufacturing delays’ for the shortage of its Vyvanse (lisdexamfetamine) ADHD drug. The actual process ...